Shanghai Shenqi Pharmaceutical Investment Management Co Ltd - Class A
SHSE:600613 (China)
Â
Class A
Â¥
8.63
(-0.92%)
Dec 4
On watch
Business Description
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
ISIN : CNE000000453
Share Class Description:
SHSE:600613: Class ACompare
Compare
Traded in other countries / regions
600613.China IPO Date
1992-08-20Description
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd is mainly engaged in pharmaceutical production and distribution in China.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.68 | |||||
| Equity-to-Asset | 0.73 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 3.13 | |||||
| Interest Coverage | 6.52 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.82 | |||||
| Beneish M-Score | -2.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.5 | |||||
| 3-Year EPS without NRI Growth Rate | -15.7 | |||||
| 3-Year FCF Growth Rate | 77 | |||||
| 3-Year Book Growth Rate | -3.8 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.97 | |||||
| 9-Day RSI | 60.83 | |||||
| 14-Day RSI | 59.79 | |||||
| 6-1 Month Momentum % | 12.69 | |||||
| 12-1 Month Momentum % | -21.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.75 | |||||
| Quick Ratio | 2.33 | |||||
| Cash Ratio | 1.21 | |||||
| Days Inventory | 69.99 | |||||
| Days Sales Outstanding | 64.53 | |||||
| Days Payable | 65.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.14 | |||||
| Dividend Payout Ratio | 0.91 | |||||
| Forward Dividend Yield % | 1.14 | |||||
| 5-Year Yield-on-Cost % | 1.14 | |||||
| Shareholder Yield % | 1.82 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.16 | |||||
| Operating Margin % | 4.25 | |||||
| Net Margin % | 2.47 | |||||
| FCF Margin % | 8.28 | |||||
| ROE % | 2.53 | |||||
| ROA % | 1.81 | |||||
| ROIC % | 3.85 | |||||
| ROC (Joel Greenblatt) % | 7.11 | |||||
| ROCE % | 3.32 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 78.45 | |||||
| PE Ratio without NRI | 78.45 | |||||
| Shiller PE Ratio | 47.94 | |||||
| PS Ratio | 1.93 | |||||
| PB Ratio | 1.97 | |||||
| Price-to-Tangible-Book | 2.36 | |||||
| Price-to-Free-Cash-Flow | 23.65 | |||||
| Price-to-Operating-Cash-Flow | 21.78 | |||||
| EV-to-EBIT | 46.33 | |||||
| EV-to-EBITDA | 46.33 | |||||
| EV-to-Revenue | 1.69 | |||||
| EV-to-FCF | 20.35 | |||||
| Price-to-Projected-FCF | 1.49 | |||||
| Price-to-Median-PS-Value | 0.92 | |||||
| Price-to-Graham-Number | 2.6 | |||||
| Price-to-Net-Current-Asset-Value | 5.91 | |||||
| Earnings Yield (Greenblatt) % | 2.16 | |||||
| FCF Yield % | 4.45 | |||||
| Forward Rate of Return (Yacktman) % | -17.59 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,386.344 | ||
| EPS (TTM) (Â¥) | 0.11 | ||
| Beta | 1.48 | ||
| Volatility % | 42.15 | ||
| 14-Day RSI | 59.79 | ||
| 14-Day ATR (Â¥) | 0.363003 | ||
| 20-Day SMA (Â¥) | 8.273 | ||
| 12-1 Month Momentum % | -21.02 | ||
| 52-Week Range (Â¥) | 6.38 - 11.81 | ||
| Shares Outstanding (Mil) | 534.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd Frequently Asked Questions
What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd(SHSE:600613)'s stock price today?
The current price of SHSE:600613 is ¥8.63. The 52 week high of SHSE:600613 is ¥11.81 and 52 week low is ¥6.38.
When is next earnings date of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd(SHSE:600613)?
The next earnings date of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd(SHSE:600613) is .
Does Shanghai Shenqi Pharmaceutical Investment Management Co Ltd(SHSE:600613) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd(SHSE:600613) is 1.14% (As of Today), Highest Dividend Payout Ratio of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd(SHSE:600613) was 1.11. The lowest was 0.12. And the median was 0.17. The  Forward Dividend Yield % of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd(SHSE:600613) is 1.14%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers